List of Tables
Table 1. Breakthrough Therapy (BT) Designation Market Trends
Table 2. Breakthrough Therapy (BT) Designation Market Drivers & Opportunity
Table 3. Breakthrough Therapy (BT) Designation Market Challenges
Table 4. Breakthrough Therapy (BT) Designation Market Restraints
Table 5. Global Breakthrough Therapy (BT) Designation Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Breakthrough Therapy (BT) Designation Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Breakthrough Therapy (BT) Designation Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Breakthrough Therapy (BT) Designation Product Type
Table 9. Key Companies Time to Begin Mass Production of Breakthrough Therapy (BT) Designation
Table 10. Global Breakthrough Therapy (BT) Designation Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breakthrough Therapy (BT) Designation as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Breakthrough Therapy (BT) Designation Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Breakthrough Therapy (BT) Designation Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Breakthrough Therapy (BT) Designation Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Breakthrough Therapy (BT) Designation Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Breakthrough Therapy (BT) Designation Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Breakthrough Therapy (BT) Designation Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Breakthrough Therapy (BT) Designation Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Breakthrough Therapy (BT) Designation Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Breakthrough Therapy (BT) Designation Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Breakthrough Therapy (BT) Designation Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Breakthrough Therapy (BT) Designation Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Breakthrough Therapy (BT) Designation Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Breakthrough Therapy (BT) Designation Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Breakthrough Therapy (BT) Designation Sales Value by Region (2019-2024) & (%)
Table 27. Global Breakthrough Therapy (BT) Designation Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Breakthrough Therapy (BT) Designation Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Breakthrough Therapy (BT) Designation Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Breakthrough Therapy (BT) Designation Sales Value, (2025-2030) & (US$ Million)
Table 31. Roche Basic Information List
Table 32. Roche Description and Business Overview
Table 33. Roche Breakthrough Therapy (BT) Designation Products, Services and Solutions
Table 34. Revenue (US$ Million) in Breakthrough Therapy (BT) Designation Business of Roche (2019-2024)
Table 35. Roche Recent Developments
Table 36. Abbvie Basic Information List
Table 37. Abbvie Description and Business Overview
Table 38. Abbvie Breakthrough Therapy (BT) Designation Products, Services and Solutions
Table 39. Revenue (US$ Million) in Breakthrough Therapy (BT) Designation Business of Abbvie (2019-2024)
Table 40. Abbvie Recent Developments
Table 41. Novartis International AG Basic Information List
Table 42. Novartis International AG Description and Business Overview
Table 43. Novartis International AG Breakthrough Therapy (BT) Designation Products, Services and Solutions
Table 44. Revenue (US$ Million) in Breakthrough Therapy (BT) Designation Business of Novartis International AG (2019-2024)
Table 45. Novartis International AG Recent Developments
Table 46. Janssen Basic Information List
Table 47. Janssen Description and Business Overview
Table 48. Janssen Breakthrough Therapy (BT) Designation Products, Services and Solutions
Table 49. Revenue (US$ Million) in Breakthrough Therapy (BT) Designation Business of Janssen (2019-2024)
Table 50. Janssen Recent Developments
Table 51. BMS Basic Information List
Table 52. BMS Description and Business Overview
Table 53. BMS Breakthrough Therapy (BT) Designation Products, Services and Solutions
Table 54. Revenue (US$ Million) in Breakthrough Therapy (BT) Designation Business of BMS (2019-2024)
Table 55. BMS Recent Developments
Table 56. Eli Lilly Basic Information List
Table 57. Eli Lilly Description and Business Overview
Table 58. Eli Lilly Breakthrough Therapy (BT) Designation Products, Services and Solutions
Table 59. Revenue (US$ Million) in Breakthrough Therapy (BT) Designation Business of Eli Lilly (2019-2024)
Table 60. Eli Lilly Recent Developments
Table 61. Gilead Basic Information List
Table 62. Gilead Description and Business Overview
Table 63. Gilead Breakthrough Therapy (BT) Designation Products, Services and Solutions
Table 64. Revenue (US$ Million) in Breakthrough Therapy (BT) Designation Business of Gilead (2019-2024)
Table 65. Gilead Recent Developments
Table 66. Sanofi Basic Information List
Table 67. Sanofi Description and Business Overview
Table 68. Sanofi Breakthrough Therapy (BT) Designation Products, Services and Solutions
Table 69. Revenue (US$ Million) in Breakthrough Therapy (BT) Designation Business of Sanofi (2019-2024)
Table 70. Sanofi Recent Developments
Table 71. Regeneron Basic Information List
Table 72. Regeneron Description and Business Overview
Table 73. Regeneron Breakthrough Therapy (BT) Designation Products, Services and Solutions
Table 74. Revenue (US$ Million) in Breakthrough Therapy (BT) Designation Business of Regeneron (2019-2024)
Table 75. Regeneron Recent Developments
Table 76. Acadia Basic Information List
Table 77. Acadia Description and Business Overview
Table 78. Acadia Breakthrough Therapy (BT) Designation Products, Services and Solutions
Table 79. Revenue (US$ Million) in Breakthrough Therapy (BT) Designation Business of Acadia (2019-2024)
Table 80. Acadia Recent Developments
Table 81. Boehringer Ingelheim Basic Information List
Table 82. Boehringer Ingelheim Description and Business Overview
Table 83. Boehringer Ingelheim Breakthrough Therapy (BT) Designation Products, Services and Solutions
Table 84. Revenue (US$ Million) in Breakthrough Therapy (BT) Designation Business of Boehringer Ingelheim (2019-2024)
Table 85. Boehringer Ingelheim Recent Developments
Table 86. Amgen Basic Information List
Table 87. Amgen Description and Business Overview
Table 88. Amgen Breakthrough Therapy (BT) Designation Products, Services and Solutions
Table 89. Revenue (US$ Million) in Breakthrough Therapy (BT) Designation Business of Amgen (2019-2024)
Table 90. Amgen Recent Developments
Table 91. AstraZeneca Basic Information List
Table 92. AstraZeneca Description and Business Overview
Table 93. AstraZeneca Breakthrough Therapy (BT) Designation Products, Services and Solutions
Table 94. Revenue (US$ Million) in Breakthrough Therapy (BT) Designation Business of AstraZeneca (2019-2024)
Table 95. AstraZeneca Recent Developments
Table 96. GlaxoSmithKline Basic Information List
Table 97. GlaxoSmithKline Description and Business Overview
Table 98. GlaxoSmithKline Breakthrough Therapy (BT) Designation Products, Services and Solutions
Table 99. Revenue (US$ Million) in Breakthrough Therapy (BT) Designation Business of GlaxoSmithKline (2019-2024)
Table 100. GlaxoSmithKline Recent Developments
Table 101. Vertex Basic Information List
Table 102. Vertex Description and Business Overview
Table 103. Vertex Breakthrough Therapy (BT) Designation Products, Services and Solutions
Table 104. Revenue (US$ Million) in Breakthrough Therapy (BT) Designation Business of Vertex (2019-2024)
Table 105. Vertex Recent Developments
Table 106. Alexion Basic Information List
Table 107. Alexion Description and Business Overview
Table 108. Alexion Breakthrough Therapy (BT) Designation Products, Services and Solutions
Table 109. Revenue (US$ Million) in Breakthrough Therapy (BT) Designation Business of Alexion (2019-2024)
Table 110. Alexion Recent Developments
Table 111. Merck Basic Information List
Table 112. Merck Description and Business Overview
Table 113. Merck Breakthrough Therapy (BT) Designation Products, Services and Solutions
Table 114. Revenue (US$ Million) in Breakthrough Therapy (BT) Designation Business of Merck (2019-2024)
Table 115. Merck Recent Developments
Table 116. Jazz Pharmaceuticals Basic Information List
Table 117. Jazz Pharmaceuticals Description and Business Overview
Table 118. Jazz Pharmaceuticals Breakthrough Therapy (BT) Designation Products, Services and Solutions
Table 119. Revenue (US$ Million) in Breakthrough Therapy (BT) Designation Business of Jazz Pharmaceuticals (2019-2024)
Table 120. Jazz Pharmaceuticals Recent Developments
Table 121. Exelixis Basic Information List
Table 122. Exelixis Description and Business Overview
Table 123. Exelixis Breakthrough Therapy (BT) Designation Products, Services and Solutions
Table 124. Revenue (US$ Million) in Breakthrough Therapy (BT) Designation Business of Exelixis (2019-2024)
Table 125. Exelixis Recent Developments
Table 126. Eisai Basic Information List
Table 127. Eisai Description and Business Overview
Table 128. Eisai Breakthrough Therapy (BT) Designation Products, Services and Solutions
Table 129. Revenue (US$ Million) in Breakthrough Therapy (BT) Designation Business of Eisai (2019-2024)
Table 130. Eisai Recent Developments
Table 131. Takeda Basic Information List
Table 132. Takeda Description and Business Overview
Table 133. Takeda Breakthrough Therapy (BT) Designation Products, Services and Solutions
Table 134. Revenue (US$ Million) in Breakthrough Therapy (BT) Designation Business of Takeda (2019-2024)
Table 135. Takeda Recent Developments
Table 136. Pfizer Basic Information List
Table 137. Pfizer Description and Business Overview
Table 138. Pfizer Breakthrough Therapy (BT) Designation Products, Services and Solutions
Table 139. Revenue (US$ Million) in Breakthrough Therapy (BT) Designation Business of Pfizer (2019-2024)
Table 140. Pfizer Recent Developments
Table 141. Key Raw Materials Lists
Table 142. Raw Materials Key Suppliers Lists
Table 143. Breakthrough Therapy (BT) Designation Downstream Customers
Table 144. Breakthrough Therapy (BT) Designation Distributors List
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
Table 148. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Breakthrough Therapy (BT) Designation Product Picture
Figure 2. Global Breakthrough Therapy (BT) Designation Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Breakthrough Therapy (BT) Designation Sales Value (2019-2030) & (US$ Million)
Figure 4. Breakthrough Therapy (BT) Designation Report Years Considered
Figure 5. Global Breakthrough Therapy (BT) Designation Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Breakthrough Therapy (BT) Designation Revenue in 2023
Figure 7. Breakthrough Therapy (BT) Designation Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Oncology Picture
Figure 9. Infectious Diseases Picture
Figure 10. Rare Diseases Picture
Figure 11. Autoimmune Diseases Picture
Figure 12. Pulmonary Diseases Picture
Figure 13. Neurological Disorders Picture
Figure 14. Others Picture
Figure 15. Global Breakthrough Therapy (BT) Designation Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Breakthrough Therapy (BT) Designation Sales Value Market Share by Type, 2023 & 2030
Figure 17. Product Picture of Hospital
Figure 18. Product Picture of Clinic
Figure 19. Product Picture of Research Institute
Figure 20. Product Picture of Laboratories
Figure 21. Product Picture of Others
Figure 22. Global Breakthrough Therapy (BT) Designation Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Breakthrough Therapy (BT) Designation Sales Value Market Share by Application, 2023 & 2030
Figure 24. North America Breakthrough Therapy (BT) Designation Sales Value (2019-2030) & (US$ Million)
Figure 25. North America Breakthrough Therapy (BT) Designation Sales Value by Country (%), 2023 VS 2030
Figure 26. Europe Breakthrough Therapy (BT) Designation Sales Value (2019-2030) & (US$ Million)
Figure 27. Europe Breakthrough Therapy (BT) Designation Sales Value by Country (%), 2023 VS 2030
Figure 28. Asia Pacific Breakthrough Therapy (BT) Designation Sales Value (2019-2030) & (US$ Million)
Figure 29. Asia Pacific Breakthrough Therapy (BT) Designation Sales Value by Country (%), 2023 VS 2030
Figure 30. South America Breakthrough Therapy (BT) Designation Sales Value (2019-2030) & (US$ Million)
Figure 31. South America Breakthrough Therapy (BT) Designation Sales Value by Country (%), 2023 VS 2030
Figure 32. Middle East & Africa Breakthrough Therapy (BT) Designation Sales Value (2019-2030) & (US$ Million)
Figure 33. Middle East & Africa Breakthrough Therapy (BT) Designation Sales Value by Country (%), 2023 VS 2030
Figure 34. Key Countries/Regions Breakthrough Therapy (BT) Designation Sales Value (%), (2019-2030)
Figure 35. United States Breakthrough Therapy (BT) Designation Sales Value, (2019-2030) & (US$ Million)
Figure 36. United States Breakthrough Therapy (BT) Designation Sales Value by Type (%), 2023 VS 2030
Figure 37. United States Breakthrough Therapy (BT) Designation Sales Value by Application (%), 2023 VS 2030
Figure 38. Europe Breakthrough Therapy (BT) Designation Sales Value, (2019-2030) & (US$ Million)
Figure 39. Europe Breakthrough Therapy (BT) Designation Sales Value by Type (%), 2023 VS 2030
Figure 40. Europe Breakthrough Therapy (BT) Designation Sales Value by Application (%), 2023 VS 2030
Figure 41. China Breakthrough Therapy (BT) Designation Sales Value, (2019-2030) & (US$ Million)
Figure 42. China Breakthrough Therapy (BT) Designation Sales Value by Type (%), 2023 VS 2030
Figure 43. China Breakthrough Therapy (BT) Designation Sales Value by Application (%), 2023 VS 2030
Figure 44. Japan Breakthrough Therapy (BT) Designation Sales Value, (2019-2030) & (US$ Million)
Figure 45. Japan Breakthrough Therapy (BT) Designation Sales Value by Type (%), 2023 VS 2030
Figure 46. Japan Breakthrough Therapy (BT) Designation Sales Value by Application (%), 2023 VS 2030
Figure 47. South Korea Breakthrough Therapy (BT) Designation Sales Value, (2019-2030) & (US$ Million)
Figure 48. South Korea Breakthrough Therapy (BT) Designation Sales Value by Type (%), 2023 VS 2030
Figure 49. South Korea Breakthrough Therapy (BT) Designation Sales Value by Application (%), 2023 VS 2030
Figure 50. Southeast Asia Breakthrough Therapy (BT) Designation Sales Value, (2019-2030) & (US$ Million)
Figure 51. Southeast Asia Breakthrough Therapy (BT) Designation Sales Value by Type (%), 2023 VS 2030
Figure 52. Southeast Asia Breakthrough Therapy (BT) Designation Sales Value by Application (%), 2023 VS 2030
Figure 53. India Breakthrough Therapy (BT) Designation Sales Value, (2019-2030) & (US$ Million)
Figure 54. India Breakthrough Therapy (BT) Designation Sales Value by Type (%), 2023 VS 2030
Figure 55. India Breakthrough Therapy (BT) Designation Sales Value by Application (%), 2023 VS 2030
Figure 56. Breakthrough Therapy (BT) Designation Industrial Chain
Figure 57. Breakthrough Therapy (BT) Designation Manufacturing Cost Structure
Figure 58. Channels of Distribution (Direct Sales, and Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
